The association between the serum level of tiRNA-Val-CAC-2 and various clinical characteristics (such as age, gender, tumor stage, tumor grade, tumor size, tumor location, smoking, serum CA199, and serum CEA levels) was evaluated using the chi-square test. This evidence concerns the gene CEACAM5 and neoplasm.